Patent · US Active

Anti-PCSK9 antibodies and uses thereof

US10858446B2 · kind B2 · utility

1Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2016
Grant dateDec 8, 2020
Priority date
Expiry dateSep 2, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-PCSK9 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as lipid disorders, metabolic diseases, hypercholesterolemia, inflammatory diseases and infectious diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.